期刊文献+

重症肌无力患者造血干/祖细胞及其亚群富集纯化的研究

Collection and purification of myasthenia gravis CD_(34)^+ hematopoietic stem (progenitor) cells and its sup-groups
下载PDF
导出
摘要 目的:获得高纯度造血干/祖细胞及其亚群,用于重症肌无力(MG)造血干细胞移植治疗和生物学特性的研究。方法:用免疫磁珠法(MiniMACS)从MG骨髓中富集CD34+细胞后再用荧光激活细胞分选(Fluorescent activatedcell sorter,FACS)纯化CD34+/CD38+和CD34+/CD38-细胞亚群。结果:MiniMACS分选的CD34+细胞群纯度达90%,FACS分选的CD34+/CD38-和CD34+/CD38+两细胞亚群纯度可达95%以上。结论:联合使用MiniMACS和FACS可迅速大量纯化HSC/HPC及其重要细胞亚群,可用于临床造血于细胞移植、基因治疗和研究HSC/HPC及其亚群生物学特性。 Objective: To collect and purify the hone marrow CD34+ hematopoietic stem cells and its sub-groups from the patients with myasthenia gravis. Methods; CD34+ cells were collected aand purified by means of imunomagnetic beads on MiniMACS device. Flow cytometry was employed to determine percentage of CD34+ cells, CD34+/CD38- cells and CD34+/CD38+ cells before and after miniMACS. and to detect cell ability after CD34+ cell purification. Results: The purity of CD34+ cells amounted to more than 90 % after the pruification, The purity of CD34+/CD38- cells and CD34+/CD38+ cells amounted to more than 95% after FACS. Conclusions: The Conbination of MiniMACS and FACS can sort effectively the bone marrow CD34+ cells and its sub-groups so that the bone marrow CD34+ cells and its sub-groups are used for hematopoietic stem cell transplantation, gene therapy and for study of HSC/HPC and its cell sub-groups.
出处 《脑与神经疾病杂志》 2004年第2期97-98,共2页 Journal of Brain and Nervous Diseases
基金 广西科技攻关项目资助(桂科攻0322025-9)
  • 相关文献

参考文献8

  • 1[1]Ikehara S, Ohtisuki H, Good RA, et al. Prevention of type 1 diabetes in monlbesediabetes nice by allogeneic bone marrow transplantation. Proc Natl Acad Sci USA, 1995,82:7742
  • 2[2]Tyndall A, and Gratwohl A. Haemopoietic stem and progenitor cells in the treatment of severe autoimmune diseases. Ann Rheum Dis, 1996,55:149
  • 3[3]Ikehara S. Bone marrow transplantation for autoimmune diseases.Acta Haematol, 1998,99:116~132
  • 4[4]Grau JW, Casademont J, Monforte R, et al. Myasthenia gravis after allogenitic bone marrow transplantation: report a new case and pathogenitic consideration. Bone Marrow Transplant, 1990, 5: 435~417
  • 5[5]Krause D, Fackler M, Civin C, et al. CD34 +: structure, biology and clinical utility. Blood 1996,87(1):1~13
  • 6[6]Terstappen LWMM, Huang S, Safford M, et al. Sequential generation of hematopoietic colonise derive from single nonlineage committed CD34 +/CD38- progentitor cells. Blood , 1991,77:1218~1277
  • 7[7]Huang S. and Terstappen L. Lymphoid and myeloid differentiatiom of singhe human CD34 + , HLA-DR+ , CD34- ,hemartopoietie stem cells. Blood, 1994, 83:1515~1525
  • 8[8]Waller E. olweus J, Lund-johansen F, et al. The "common stem cell" hypothesis reevaluated: human fetal bone marrow contains separate population of hematopoietic and stroaml progenitors.Blood, 1995,85: 2422~2435

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部